GILEAD SCIENCES, INC. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
GILEAD SCIENCES, INC. (GILD) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $15.00 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2026-05-07
- 2026-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $15.00M.
- 2025-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $70.00M.
- 2025-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $19.00M.
- 2025-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $79.00M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One as first filed |
|---|---|---|
| 2026-03-31 | $15.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $70.00M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $19.00M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $79.00M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $1.27B 10-K · filed 2024-02-23 | |
| 2023-09-30 | $1.23B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.01B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.01B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $1.06B 10-K · filed 2023-02-22 | |
| 2022-09-30 | $1.02B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $962.00M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.09B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $1.19B 10-K · filed 2022-02-23 | |
| 2021-09-30 | $1.39B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.69B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.90B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.52B 10-K · filed 2021-02-25 | |
| 2020-09-30 | $11.29B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $12.62B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $11.42B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $15.01B 10-K · filed 2020-02-25 | |
| 2019-09-30 | $16.86B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $22.01B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $22.31B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $22.79B 10-K · filed 2019-02-26 | |
| 2018-09-30 | $21.13B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $16.86B 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $16.59B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $23.14B 10-K · filed 2018-02-27 | |
| 2016-12-31 | $9.38B 10-K · filed 2017-02-27 | |
| 2015-12-31 | $11.92B 10-K · filed 2016-02-24 | |
| 2014-12-31 | $8.03B 10-K · filed 2015-02-25 | |
| 2014-09-30 | $5.16B 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $5.96B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $5.12B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $1.51B 10-K · filed 2014-02-25 | |
| 2013-09-30 | $1.65B 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $1.95B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $1.71B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.47B 10-K · filed 2013-02-27 | |
| 2012-09-30 | $1.25B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.33B 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $518.25M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $9.03B 10-K · filed 2013-02-27 | $1.57B 10-K · filed 2012-02-23 |
| 2011-09-30 | $1.73B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $1.67B 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $2.97B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $1.73B 10-K · filed 2012-02-23 | $1.21B 10-K · filed 2011-02-28 |
| 2010-09-30 | $1.41B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $558.84M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $429.98M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |